1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular DegenerationNeovascular Age-related Macular Degeneration (nAMD)Active, not recruitingPhase 42026-07-31NCT06795048